Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In an angiographic substudy of the GUSTO trial data, published in the New England Journal of Medicine, t-PA led to earlier opening
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury